JNJ News Alert Johnson & Johnson (JNJ) 108.51 12/06/2014 22:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Johnson & Johnson (JNJ) 108.51 $JNJ

BP's Dividend Hors D'oeuvres
Eli Inkrot - Seeking Alpha - Sat Dec 06, 1:07PM CST
Recently I have been enamored with the idea of "dividend hors d'oeuvres" as brought about by fellow Seeking Alpha contributor Tim McAleenan Jr. referring to the phrasing of legendary investor John Neff. I suppose I have always had this...
JNJ: 108.51 (+0.95), BP: 39.98 (-0.41)

Final Glance: Pharmaceuticals companies
AP - Fri Dec 05, 5:02PM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
JNJ: 108.51 (+0.95), BAX: 74.22 (+0.65), PFE: 31.99 (+0.32), BMY: 60.65 (+1.76)

Final Glance: Medical Devices companies
AP - Fri Dec 05, 5:02PM CST
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
ZMH: 114.96 (+1.00), JNJ: 108.51 (+0.95), MDT: 75.04 (+1.10), BAX: 74.22 (+0.65)

What Eli Lilly Can Do To Keep Its Amazing Rally Going In 2015
Bob Ciura - at Seeking Alpha - Fri Dec 05, 4:07PM CST

JNJ: 108.51 (+0.95), PFE: 31.99 (+0.32), AZN: 73.72 (-0.22), LLY: 71.85 (-0.53)

12 Unexpected Stocks Bringing Buffett and Fellow Billionaires Holiday Cheer
at The Street - Fri Dec 05, 2:20PM CST
This holiday season, some Wall Street billionaires have more to celebrate than others. But the most rewarding stocks under their trees this year may surprise you.
RAI: 66.90 (-0.03), VIPS: 22.21 (+0.46), ARII: 56.31 (-0.77), LO: 63.69 (-0.21), TAP: 74.92 (+1.66), ILMN: 189.90 (-0.93), GOOG: 525.26 (-12.05), BITA: 74.57 (-3.64), DSKY: 17.97 (-1.00), WWAV: 34.55 (+0.03), TTWO: 27.81 (-0.13), JNJ: 108.51 (+0.95), RYAAY: 68.04 (-0.04), ESRX: 84.58 (+0.55), DVA: 75.63 (+0.33), EGO: 6.64 (-0.15), MHK: 155.49 (+0.71), FNV: 50.84 (-1.57), GLD: 114.43 (-1.45), RGLD: 66.91 (-1.45), SNY: 46.75 (unch), GRPN: 7.27 (-0.13), AAPL: 115.00 (-0.49)

Biotech industry group supports adding Ebola to Voucher Program Act
Seeking Alpha - at Seeking Alpha - Fri Dec 05, 12:57PM CST

JNJ: 108.51 (+0.95), BCRX: 10.27 (+0.35), CMRX: 38.03 (+1.28), HEB: 0.26 (+0.01), SRPT: 15.22 (unch), MRK: 61.49 (+0.57), NLNK: 37.29 (+0.85), TKMR: 12.83 (-0.18), GSK: 46.04 (+0.15)

Update: FDA Clears Johnson & Johnson's Insulin Pump, An Artificial Pancreas Quickened
Andy Batts - at Seeking Alpha - Fri Dec 05, 12:31PM CST

JNJ: 108.51 (+0.95), DXCM: 55.31 (+0.72)

Midday Glance: Pharmaceuticals companies
AP - Fri Dec 05, 12:17PM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
JNJ: 108.51 (+0.95), BAX: 74.22 (+0.65), PFE: 31.99 (+0.32), BMY: 60.65 (+1.76)

Midday Glance: Medical Devices companies
AP - Fri Dec 05, 12:17PM CST
NEW YORK (AP) — Shares of some top medical devices companies are up at 1 p.m.:
ZMH: 114.96 (+1.00), JNJ: 108.51 (+0.95), MDT: 75.04 (+1.10), BAX: 74.22 (+0.65)

Stocks Hold Small Gains; Taser Hits New High
at Investor's Business Daily - Fri Dec 05, 10:51AM CST
Stocks were still only modestly higher near Friday's midday, despite a blowout job report. The Nasdaq rose 0.3% and the S&P 500 0.2%. The Dow Jones industrial average climbed 0.4% to a record high, thanks in part to gains in Goldman Sachs (GS) and...
AMBA: 54.69 (-0.94), JNJ: 108.51 (+0.95), GS: 195.45 (+3.50), ULTA: 129.75 (+4.01), FIVE: 37.61 (-5.24), TASR: 24.82 (+0.67)

Early Glance: Pharmaceuticals companies
AP - Fri Dec 05, 9:28AM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
JNJ: 108.51 (+0.95), BAX: 74.22 (+0.65), PFE: 31.99 (+0.32), BMY: 60.65 (+1.76)

Early Glance: Medical Devices companies
AP - Fri Dec 05, 9:28AM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
ZMH: 114.96 (+1.00), JNJ: 108.51 (+0.95), MDT: 75.04 (+1.10), BAX: 74.22 (+0.65)

Hydration could save many Ebola victims
Seeking Alpha - at Seeking Alpha - Fri Dec 05, 6:19AM CST

JNJ: 108.51 (+0.95), BCRX: 10.27 (+0.35), HEB: 0.26 (+0.01), SRPT: 15.22 (unch), MRK: 61.49 (+0.57), NLNK: 37.29 (+0.85), TKMR: 12.83 (-0.18), GSK: 46.04 (+0.15), IXJ: 103.92 (+0.49), IRY: 48.89 (-0.16)

BRIC Hernia Repair Market Outlook to 2020: Key players covered include Covidien, Ethicon and C.R. Bard.
M2 - Fri Dec 05, 5:42AM CST
Research and Markets (http://www.researchandmarkets.com/research/qf9c2h/bric_hernia) has announced the addition of the "BRIC Hernia Repair Market Outlook to 2020" report to their offering. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Hernia Repair market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Key Topics Covered: 1 List of Tables 2 Introduction 3 Hernia Repair Market, BRIC 4 Hernia Repair Market, Brazil 5 Hernia Repair Market, Russia 6 Hernia Repair Market, India 7 Hernia Repair Market, China 8 Overview of Key Companies in BRIC Hernia Repair Market 9 Appendix Companies Mentioned: - C. R. Bard, Inc. - Covidien plc - Johnson & Johnson - B. Braun Melsungen AG For more information visit http://www.researchandmarkets.com/research/qf...ric_hernia
JNJ: 108.51 (+0.95)

Global and Chinese Liquid Toothpaste Industry Report 2014
M2 - Fri Dec 05, 3:05AM CST
Research and Markets (http://www.researchandmarkets.com/research/zxttqq/global_and) has announced the addition of the "Global and Chinese Liquid Toothpaste Industry Report 2014" report to their offering. The Global and Chinese Liquid Toothpaste Industry Report 2014 is a professional and in-depth study on the current state of the global liquid toothpaste industry with a focus on the Chinese situation. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The liquid toothpaste market analysis is provided for both the international and Chinese domestic situations including development trends, competitive landscape analysis, key regions development status and a comparison analysis between the international and Chinese markets. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Liquid toothpaste industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided. The report focuses on twelve industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The liquid toothpaste industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. Key Topics Covered: - Liquid Toothpaste Industry Overview - Liquid Toothpaste International and China Market Analysis - Liquid Toothpaste Technical Data and Manufacturing Plants Analysis - Liquid Toothpaste Production by Regions by Technology by Application - Liquid Toothpaste Manufacturing Process and Cost Structure - 2009-2014 Liquid Toothpaste Productions Supply Sales Demand Market Status and Forecast - Liquid Toothpaste Key Manufacturers Analysis - Up and Down Stream Industry Analysis - Liquid Toothpaste Marketing Channels Analysis - Liquid Toothpaste Industry Development Trend - Liquid Toothpaste Industry Development Proposals - Liquid Toothpaste New Project Investment Feasibility Analysis - Global and China Liquid Toothpaste Industry Research Conclusions Companies Mentioned - Boryung (KR) - Church & Dwight (US) - Colgate-Palmolive (US) - DIO (KR) - Fengshiqi Biotechnology (CN) - GlaxoSmithKline (UK) - Henkel (DE) - Johnson & Johnson (US) - LION (JP) - P&G (US) - Sunstar (JP) - Zettoc (JP) For more information visit http://www.researchandmarkets.com/research/zxttqq/global_and
JNJ: 108.51 (+0.95), GSK: 46.04 (+0.15)

How Much Do Fair-Value Estimates Help The Retail Investor?
Le Statisticien - Seeking Alpha - Fri Dec 05, 12:10AM CST
How much do fair-value metrics for Johnson & Johnson (NYSE: JNJ ) help us to understand and deal with its market-price patterns? More generally, to what extent do fair-value metrics provide useful information in helping individual investors to...
JNJ: 108.51 (+0.95)

Will MedTech Gain from Republican Promises? - Zacks Analyst Interviews
Zacks Equity Research - Zacks Investment Research - Fri Dec 05, 12:00AM CST
Will MedTech Gain from Republican Promises? - Zacks Analyst Interviews
ABT: 45.30 (-0.19), JNJ: 108.51 (+0.95), MDT: 75.04 (+1.10), STE: 65.20 (+1.70), BAX: 74.22 (+0.65), COV: 103.68 (+1.18), SHPG: 215.07 (-0.94), STJ: 69.95 (+0.62), ABBV: 69.71 (+0.14), WAG: 68.60 (+0.70), SYK: 94.62 (+0.24)

Will MedTech Gain from Republican Promises? - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Fri Dec 05, 12:00AM CST
Will MedTech Gain from Republican Promises? - Industry Outlook
ABT: 45.30 (-0.19), JNJ: 108.51 (+0.95), MDT: 75.04 (+1.10), STE: 65.20 (+1.70), BAX: 74.22 (+0.65), COV: 103.68 (+1.18), SHPG: 215.07 (-0.94), STJ: 69.95 (+0.62), ABBV: 69.71 (+0.14), WAG: 68.60 (+0.70), SYK: 94.62 (+0.24)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

SPECS Framework: Rethinking Career Growth Strategies

Updated Category News Views 61

An Evolving Workplace Demands Evolving Strategies Look, careers ain't what they used to be—and they shouldn't be. Today’s world is flipping the script on how we work, and Dr. Brandi R. Muñoz is rewriting the book on career development with her SPECS framework. The guy clinging to his outdated Rolodex for advice isn't gonna cut it anymore. "Who Are Your SPECS?...

Continue Reading
Bird-X Welcomes Doolittle to Elevate Sales Strategy

Updated Category News Views 105

Change in Flight: Bird-X Eyes Strategic Growth Well, here's one that might spread its wings wide. Emanuel Doolittle has joined Bird-X, Inc. as Director of Sales and Business Development. Now, let's not beat around the bush — Bird-X isn't a name you'd see thrown around daily stock talks, but it's stirring up interest in the pest control sector without question. Why...

Continue Reading
Goodal Skincare Capitalizes on K-Beauty Craze at Costco

Updated Category News Views 38

A Venture into American Retail Goodal, the darling of Korea's skincare scene, is staking its claim at Costco. This is no small feat, my friends. We're talkin' about a brand that's carved out a sweet niche with its Green Tangerine line. Now it's hitching its wagon to one of America's retail behemoths, known for its unique knack in beauty products. From Olive Young to...

Continue Reading
DUPR Teams Up with InBody to Elevate Pickleball Fitness

Updated Category News Views 0

Well, here's a twist in the pickleball world—DUPR and InBody have struck a deal to bring top-notch body composition tech to the ever-expanding universe of pickleballers. They're merging power players from two different worlds to tap into your performance on the court and your wellness off it. Maybe I'm just jaded from too many marketing pitches, but this one could...

Continue Reading
PG&E's $2B Delay: A Blame Game or Real Crisis?

Updated Category News Views 163

Just when you think the circus of energy utilities couldn't get any more outlandish, PG&E grabs the spotlight once more. Picture this: they've got the megaphone out, threatening to put the brakes on $2 billion in crucial infrastructure investments. Twenty-five thousand customers left hanging, just waiting for their lights to come on. As if that's not enough, PG&E is also...

Continue Reading
Telemed Sites Need Solid Payment Systems with AI

Updated Category News Views 54

Brace for Impact: Payment Processors in Telehealth A new era is brewing in telehealth, with AI coding tools making website creation a breeze for healthcare folks. But here's the kicker: accepting credit cards is not as easy as setting up a snazzy booking page. Take it from Organic Payment Gateways in good ol' Scarborough, Maine, who've decided to toss their hat into this...

Continue Reading
Luxury Vinyl Tiles Market Set for Steady Growth to 2031

Updated Category News Views 69

Luxury Vinyl Tiles: A Market on the Rise Well, folks, the flooring game is picking up steam, and luxury vinyl tiles (LVT) are in the spotlight. With consumers and businesses all looking for something durable yet easy on the eyes and wallet, LVT is answering the call. MarketsandMarkets™ reports that this sector is expected to balloon from USD 18.22 billion in 2026 to USD...

Continue Reading
Bright Minds in Hot Water: Investigation Shakes Investors

Updated Category News Views 91

FDA Throws Wrench Into Bright Minds' Plans This ain't the first time a biotech company's dream has hit the skids, but Bright Minds Biosciences (NASDAQ:DRUG) found themselves in the meat grinder when the FDA threw their epilepsy trial plans under the bus. The partial clinical hold wasn't a gentle slap on the wrist, but a gut punch driven by mouse toxicity findings and...

Continue Reading
ESAC Redefines Entertainment Centers, Eyes 2027 Trends

Updated Category News Views 107

A New Era for Family Entertainment Centers Forget the traditional FEC with its solitary rides; the future's all about constructing social destinations that blend immersive storytelling and hybrid offerings. Elephant Sculpture Art Co., Ltd. (ESAC) is at the forefront, drawing from their Shanghai WUNPARK project to reimagine the design of these amusement hubs. Set to engage...

Continue Reading
AMETEK Surpasses Q3 2026 Expectations, Raises Outlook

Updated Category News Views 11

A Banner Quarter for AMETEK Holy smokes, AMETEK has thrown down some numbers for the third quarter of 2026 that would make any seasoned trader sit up and take notice. We’re talking record-breaking across the board: $2.22 billion in sales, marking a whopping 17% increase over last year. Now, that's not just growth—that's rocket fuel. Earnings per share rocketed up with...

Continue Reading

Top 5 Most Recently Viewed Articles

ThredUp Reports Q3 2024 Financial Results; Outlook Brightens

Updated Category News Views 55

ThredUp Financial Results for the Third Quarter In the recently concluded third quarter, ThredUp Inc. (NASDAQ: TDUP) reported total revenue of $73 million, marking an 11% decline year-over-year. This decline stems from various market factors influencing the resale industry. Revenue Breakdown and Margins The U.S. market alone contributed $61.5 million to the overall...

Continue Reading
Tesla Faces Sales Challenges in Europe Amidst Controversies

Updated Category News Views 372

Tesla's Declining Sales in Key European Markets Tesla Inc (NASDAQ: TSLA) is facing significant sales declines in several European countries as reported in early 2025. These drops, drastic in some cases, seem to be a reflection of growing consumer dissatisfaction linked to CEO Elon Musk's heightened political involvement. The Impact of Elon Musk's Political Engagement As...

Continue Reading
Dermata Therapeutics Faces Market Challenges with Stock at $1.28

Updated Category News Views 48

Dermata Therapeutics and its Recent Stock Performance In a highly competitive market landscape, Dermata Therapeutics Inc. (DRMA) has experienced a significant decline in stock value, recently hitting a 52-week low of $1.28. As a biotechnology company specializing in dermatological treatments, Dermata has encountered considerable challenges over the past year, resulting in...

Continue Reading
Indonesia Advances in Critical Minerals for EV & Green Technologies

Updated Category News Views 138

Indonesia's Commitment to the Critical Minerals Industry Fastmarkets proudly reveals an important partnership with the Ministry of Investment and Downstream Industry of Indonesia. This collaboration highlights Indonesia's strategy to boost its role in the global supply chain of critical minerals, aiming to support a sustainable economy centered around clean energy...

Continue Reading
Cox Automotive Revolutionizes Vehicle Appraisal with AI

Updated Category News Views 270

Cox Automotive's Innovative Integration with UVeye Cox Automotive is at the forefront of automotive technology, consistently advancing how dealerships operate. In a recent development, they have integrated their distinctive vAuto platform with UVeye. This integration marks a significant milestone in improving vehicle appraisal processes, allowing for greater efficiency...

Continue Reading